Sharon Baer-Hassin

Tel Aviv, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 136 publications

Exploratory Prospective Study of Self-Titrated Medical Cannabis for Nonmotor Symptoms in Parkinson's Disease.

Exploratory Prospective Study of Self-Titrated Medical Cannabis for Nonmotor Symptoms in Parkinson's Disease.

Journal: Cannabis and cannabinoid research

Published: June 17, 2026

Vestibular schwannoma associated normal pressure hydrocephalus: clinical features and shunt responsiveness compared with idiopathic NPH.

Vestibular schwannoma associated normal pressure hydrocephalus: clinical features and shunt responsiveness compared with idiopathic NPH.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: June 12, 2026

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: medRxiv : the preprint server for health sciences

Published: March 27, 2026

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

The GBA1 p.E427K (p.E388K) Variant Is a Risk Factor for Synucleinopathies: A Meta-Analysis.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 18, 2026

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Rare-Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 10, 2026

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results.

Journal: Neurology and therapy

Published: February 27, 2026

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Rare-variant burden across lysosomal genes implicates sialylation and ganglioside metabolism in Parkinson's disease.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2026

Resolution of chronic refractory migraine and development of burning mouth syndrome after focused ultrasound thalamotomy: illustrative case.

Resolution of chronic refractory migraine and development of burning mouth syndrome after focused ultrasound thalamotomy: illustrative case.

Journal: Journal of neurosurgery. Case lessons

Published: December 31, 2025

Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.

Pathogenic or Likely Pathogenic GRN Variants Are Found in 0.1% of Parkinson's Disease Patients.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 12, 2025

Lack of association between G6PD variants and Parkinson disease.

Lack of association between G6PD variants and Parkinson disease.

Journal: HGG advances

Published: May 08, 2025

Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.

Genetic testing for Parkinson's disease in Israel: Insights from the Rostock Parkinson's Disease (ROPAD) study.

Journal: Parkinsonism & related disorders

Published: March 09, 2025

The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.

The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.

Journal: Human molecular genetics

Published: January 20, 2025

Showing 1-12 of 136

Last Updated: 09/26/2026